---
figid: PMC11860879__fimmu-16-1542326-g002
figtitle: Multiple signaling pathways in the non-immune TME in AOC
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11860879
filename: fimmu-16-1542326-g002.jpg
figlink: /pmc/articles/PMC11860879/figure/F2/
number: F2
caption: Multiple signaling pathways in the non-immune TME in AOC. ATP7A/B causes
  the efflux of platinum drugs. PI3K/AKT/mTOR signaling pathway promotes tumor proliferation,
  induces EMT and enhances tumor metastasis, inhibits apoptosis and protects against
  autophagy in AOC. RAS/RAF/MAPK signaling pathway promotes proliferation in tumor.
  Wnt/β-catenin signaling pathway stimulates cell proliferation and abnormal glycolysis
  in AOC. BRCA cause DNA damage repair
papertitle: 'A new strategy for the treatment of advanced ovarian cancer: utilizing
  nanotechnology to regulate the tumor microenvironment'
reftext: Zixuan Xiong, et al. Front Immunol. 2025;16(NA).
year: '2025'
doi: 10.3389/fimmu.2025.1542326
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media SA
keywords: advanced ovarian cancer (AOC) | tumor microenvironment (TME) | chemo-immunotherapy
  | drug resistance | nanotechnology
automl_pathway: 0.9410484
figid_alias: PMC11860879__F2
figtype: Figure
redirect_from: /figures/PMC11860879__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11860879__fimmu-16-1542326-g002.html
  '@type': Dataset
  description: Multiple signaling pathways in the non-immune TME in AOC. ATP7A/B causes
    the efflux of platinum drugs. PI3K/AKT/mTOR signaling pathway promotes tumor proliferation,
    induces EMT and enhances tumor metastasis, inhibits apoptosis and protects against
    autophagy in AOC. RAS/RAF/MAPK signaling pathway promotes proliferation in tumor.
    Wnt/β-catenin signaling pathway stimulates cell proliferation and abnormal glycolysis
    in AOC. BRCA cause DNA damage repair
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP7A
  - ATP7B
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - EGFR
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - SHE
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CTNNB1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ATM
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - GSK3B
  - RPS6KB1
  - RPS6KB2
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - BRCA1
  - BRCA2
  - MTOR
  - MEF2D
  - EGF
  - Ras
  - Platinum
  - MEK
  - Nucleus
  - cancer
  - Ovarian cancer
---
